Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer

Meta-Analysis of MMP2 –1306T Allele as a Protective Factor in Digestive Cancer

(2011) Le-yao Zhang et al.   ARCHIVES OF MEDICAL RESEARCH

Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: Correlation with a favorable clinical outcome

(2011) Helge Stenvold et al.   LUNG CANCER

Candidate gene studies in gallbladder cancer: A systematic review and meta-analysis

(2011) Kshitij Srivastava et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley

(2011) Balraj Mittal et al.   Saudi Journal of Gastroenterology

A single nucleotide polymorphism in the matrix metalloproteinase 2 promoter is closely associated with high risk of nasopharyngeal carcinoma in Cantonese from southern China

(2011) Jian-Yong Shao et al.   Chinese Journal of Cancer

Role of MMP-3 and MMP-9 and Their Haplotypes in Risk of Bladder Cancer in North Indian Cohort

(2010) Priyanka Srivastava et al.   ANNALS OF SURGICAL ONCOLOGY

Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility

(2010) Yu-Chiao Yi et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Association of Matrix Metalloproteinases 1, 7, and 9 Gene Polymorphisms with Genetic Susceptibility to Colorectal Carcinoma in a Han Chinese Population

(2010) Wen-Liang Fang et al.   DNA AND CELL BIOLOGY

Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer

(2010) Kyung Sook Park et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk

(2010) B. Peng et al.   MUTAGENESIS

Matrix Metalloproteinase-2 Polymorphisms and Breast Cancer Susceptibility

(2009) A. Beeghly-Fadiel et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Transforming Growth Factor-B1 and Matrix Metalloproteinase-7 Promoter Variants Induce Risk for Helicobacter pylori–Associated Gastric Precancerous Lesions

(2009) B.R. Achyut et al.   DNA AND CELL BIOLOGY

Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer

(2009) Rebecca Brooks et al.   GYNECOLOGIC ONCOLOGY

Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China

(2009) Yan Li et al.   MOLECULAR BIOLOGY REPORTS

Role of Immunohistochemical Overexpression of Matrix Metalloproteinases MMP-2 and MMP-11 in the Prognosis of Death by Ovarian Cancer

(2008) Martine Périgny et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

No Association of MMP-7, MMP-8, and MMP-21 Polymorphisms with the Risk of Hepatocellular Carcinoma in a Chinese Population

(2008) W. Qiu et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Associations of Matrix Metalloproteinase-9 Protein Polymorphisms with Lymph Node Metastasis but not Invasion of Gastric Cancer

(2008) Y. Tang et al.   CLINICAL CANCER RESEARCH

Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population

(2008) L. Yang et al.   EJSO

MMP-7 (−181A>G) promoter polymorphisms and risk for cervical cancer

(2008) HariOm Singh et al.   GYNECOLOGIC ONCOLOGY

Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer

(2008) E. Vairaktaris et al.   ORAL ONCOLOGY